95 related articles for article (PubMed ID: 7145024)
1. Unremitting suppression of the postovariectomy rise in plasma LH by tumor-induced hyperprolactinemia.
Login IS; Krieg RJ; Kaiser DL; Thorner MO; MacLeod RM
Neuroendocrinology; 1982 Nov; 35(5):327-32. PubMed ID: 7145024
[TBL] [Abstract][Full Text] [Related]
2. Progesterone administration prolongs the inhibitory effects of hyperprolactinemia on luteinizing hormone secretion in acutely ovariectomized rats.
Carter DA; Whitehead SA
Biol Reprod; 1983 Mar; 28(2):285-8. PubMed ID: 6838947
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of exogenously induced hyperprolactinemia on the endogenous cyclic release of luteinizing hormone and prolactin in the estrogen-primed ovariectomized rat.
Cohen-Becker IR; Selmanoff M; Wise PM
Endocrinology; 1986 Oct; 119(4):1718-25. PubMed ID: 3757909
[TBL] [Abstract][Full Text] [Related]
4. The effect of hyperprolactinemia produced by transplantable pituitary MtTW15 tumor cells in male rats on hypothalamic luteinizing hormone-releasing hormone release in vitro: effects of naloxone and K+.
Kalra PS; Kalra SP
Endocrinology; 1987 Jul; 121(1):310-5. PubMed ID: 3297642
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by prolactin of post-castration rise in LH.
Grandison L; Hodson C; Chen HT; Advis J; Simpkins J; Meites J
Neuroendocrinology; 1977; 23(5):312-22. PubMed ID: 339120
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin secretion in rats bearing a prolactin-secreting pituitary tumor: effects of naloxone administration.
Lamberts SW; Zuiderwijk JM; Bons EG; Uitterlinden P; de Jong FH
Fertil Steril; 1981 May; 35(5):557-62. PubMed ID: 6785115
[TBL] [Abstract][Full Text] [Related]
7. Hyperprolactinemia and estrogen-induced rhythms in LH and prolactin release in the ovariectomized rat.
Carr L; Rotten D; Scherrer H; Kordon C
Experientia; 1985 Apr; 41(4):494-6. PubMed ID: 3987873
[TBL] [Abstract][Full Text] [Related]
8. Alterations of testicular function induced by hyperprolactinemia in the rat.
Katovich MJ; Cameron DF; Murray FT; Gunsalus GL
J Androl; 1985; 6(3):179-89. PubMed ID: 4039718
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent suppression of postcastration luteinizing hormone secretion exerted by exogenous prolactin administration in male rats: a model for studying hyperprolactinemic hypogonadism.
Park SK; Selmanoff M
Neuroendocrinology; 1991 Apr; 53(4):404-10. PubMed ID: 2046873
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinemia alters the frequency and amplitude of pulsatile luteinizing hormone secretion in the ovariectomized rat.
Cohen-Becker IR; Selmanoff M; Wise PM
Neuroendocrinology; 1986; 42(4):328-33. PubMed ID: 3515222
[TBL] [Abstract][Full Text] [Related]
11. Effects of tumor-induced hyperprolactinemia on LH secretion following stimulation of the medial preoptic area, pituitary responsiveness and the estrogen-induced LH surge.
Shu C; Selmanoff M
Neuroendocrinology; 1991 Sep; 54(3):227-35. PubMed ID: 1944810
[TBL] [Abstract][Full Text] [Related]
12. Effects of estradiol benzoate and castration on LH in experimental hyperprolactinemia.
Tresguerres JA; Esquifino AI; Calderon AL
J Steroid Biochem; 1983 Jul; 19(1B):447-53. PubMed ID: 6887880
[TBL] [Abstract][Full Text] [Related]
13. Posterior pituitary involvement in the control of luteinizing hormone and prolactin secretion during the estrous cycle.
Froehlich JC; Ben-Jonathan N
Endocrinology; 1984 Apr; 114(4):1059-64. PubMed ID: 6423366
[TBL] [Abstract][Full Text] [Related]
14. Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats.
Leadem CA; Kalra SP
Neuroendocrinology; 1985 Oct; 41(4):342-52. PubMed ID: 4047342
[TBL] [Abstract][Full Text] [Related]
15. Effects of a prolactin-secreting pituitary tumor on hypothalamic, gonadotropic and testicular function in male rats.
Hodson CA; Simpkins JW; Pass KA; Aylsworth CF; Steger RW; Meiters J
Neuroendocrinology; 1980; 30(1):7-10. PubMed ID: 6986576
[TBL] [Abstract][Full Text] [Related]
16. LH and prolactin in estrogenized female rats: response to LHRH.
Vaticón MD; Aguilar E; Fernández-Galaz C; Tejero A
Rev Esp Fisiol; 1980 Dec; 36(4):371-6. PubMed ID: 7012967
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporine on circulating levels of prolactin, LH, FSH, TSH and GH in chronic hyperprolactinemic male rats.
Lafuente A; Alvarez-Demanuel E; Blanco A; García-Bonacho M; Esquifino AI
Rev Esp Fisiol; 1996 Sep; 52(3):161-6. PubMed ID: 8974151
[TBL] [Abstract][Full Text] [Related]
18. In vivo release of dopamine, luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in male rats bearing a prolactin-secreting tumor.
Voogt JL; de Greef WJ; Visser TJ; de Koning J; Vreeburg JT; Weber RF
Neuroendocrinology; 1987 Aug; 46(2):110-6. PubMed ID: 3114662
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
[TBL] [Abstract][Full Text] [Related]
20. LH-RH and dopamine levels in hypophysial stalk plasma and their relationship to plasma gonadotrophins and prolactin levels in male rats bearing a prolactin- and adrenocorticotrophin-secreting pituitary tumor.
Weber RF; de Greef WJ; de Koning J; Vreeburg JT
Neuroendocrinology; 1983; 36(3):205-10. PubMed ID: 6300718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
